An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Academy, ADA, and ASHA Announce the Introduction of MAAIA in the Senate
The American Academy of Audiology, Academy of Doctors of Audiology (ADA), and American Speech-Language-Hearing Association (ASHA) are pleased to announce the introduction of the Medicare…
Admission Rates of Neonatal Intensive Care Units in the United States
Pediatric audiology case-history questionnaires often ask about birth history and time spent in a neonatal intensive care unit (NICU). As such, audiologists who routinely see…
A New Flexible Auditory Brainstem Implant
An auditory brainstem implant (ABI) provides the sensation of sound to individuals who are deaf due to neurofibromatosis 2 (NF2) or a severely compromised or…